Tamoxifen and Letrozole (Fertility) Interaction

Understanding the Tamoxifen and Letrozole (Fertility) Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Tamoxifen belongs to the Selective Estrogen Receptor Modulator (SERM) class and Letrozole (Fertility) belongs to the Aromatase Inhibitor (Off-Label Fertility) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Taking tamoxifen can lower the amount of letrozole in the blood by an average of 38 percent. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Tamoxifen has 10 total documented interactions on file in this dataset, and Letrozole (Fertility) has 4. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may monitor your progress, but the drugs can be used one after the other without losing effectiveness. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Tamoxifen or Letrozole (Fertility) based on a web page, speak with your prescriber or pharmacist before making any change.